KYTHERA BIOPHARMACEUTICALS INC 4/A
4/A · KYTHERA BIOPHARMACEUTICALS INC · Filed Feb 3, 2015
Insider Transaction Report
Form 4/AAmended
Rich Douglas A.
Vice President Operations
Transactions
- Award
Stock Option (right to buy)
2015-01-29+28,217→ 28,217 totalExercise: $38.53Exp: 2025-01-29→ Common Stock (28,217 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2015 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to continued employment through each such vesting date.
- [F2]The purpose of this amendment is to correctly report the title of the derivative security in Table II, Box 1. Except as otherwise noted in this Form 4/A, all other information disclosed in the reporting person's original Form 4 filed with the Securities and Exchange Commission on February 2, 2015 was accurately reported.